News Janssen leads effort to cut waste in digital health devices A consortium of industry and academic groups – led by Johnson & Johnson's pharma division Janssen – has been set up to tackle the environmental impact of
Oncology LSX2026: Addressing adult eye cancer, with Roi Raz Roi Raz, CEO of ReBio Pharma, discusses injectable, bioresorbable sustained release delivery for ophthalmic therapeutics at LSX 2026.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.